Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 06.12.17 in Vol 5, No 12 (2017): December

This paper is in the following e-collection/theme issue:

Works citing "Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment"

According to Crossref, the following articles are citing this article (DOI 10.2196/mhealth.8349):

(note that this is only a small subset of citations)

  1. Russell L, Pascoe MC, Seymour JF, Aranda S, Butow P, Gough K, Schofield P. The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials. BMC Research Notes 2019;12(1)
  2. Crawford SY, Boyd AD, Nayak AK, Venepalli NK, Cuellar S, Wirth SM, Hsu GI. Patient-centered design in developing a mobile application for oral anticancer medications. Journal of the American Pharmacists Association 2019;59(2):S86
  3. Zackon AYL, Ayers AA, Yeager KA, Somma ML, Friedberg JW, Flowers CR, Nastoupil LJ. Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs. Leukemia & Lymphoma 2019;:1
  4. Cannella L, Efficace F, Giesinger J. How should we assess patient-reported outcomes in the onco-hematology clinic?. Current Opinion in Supportive and Palliative Care 2018;:1
  5. Skrabal Ross X, Gunn KM, Patterson P, Olver I. Mobile-Based Oral Chemotherapy Adherence–Enhancing Interventions: Scoping Review. JMIR mHealth and uHealth 2018;6(12):e11724
  6. Given CW, Given BA, Sikorskii A, Krauss JC, Vachon E. Challenges to the design and testing supportive interventions for cancer patients treated with oral oncolytic agents. Supportive Care in Cancer 2018;26(12):3975